Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood triglyceride amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000360,serum triglyceride level,,,,319.47056,mg/dl,34.5134,91.314,MMO:0000328,solid phase colorimetry,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days),110226,vildagliptin (30 mg/kg/d) (for 106 days) 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood triglyceride amount,,RS:0004580,GK/Jcl,male,154 days,7,,CMO:0000360,serum triglyceride level,,,,153.09808,mg/dl,13.2744,35.1208,MMO:0000328,solid phase colorimetry,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days),110228,vildagliptin (30 mg/kg/d) (for 106 days)